Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews · Emergency and Critical Care

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 100%Moderate 0 · 0%High 0 · 0%

Serious adverse eventsÂ

Canakinumab showed no clear difference in serious adverse eventsÂ compared with standard care/placebo (low certainty).

1 finding from 1 review

Interleukin‐1 blocking agents for treating COVID‐19 2022 · Cochrane Headline outcomes only
RR 0.8 [0.57, 1.13]
2 studies · 499 participants
Low